Pressure BioSciences announced the receipt of an Open Order Agreement for the purchase in 2024 of a minimum of 10,000 bottles of the Company’s Nano-CBD Topical Spray, with an initial product shipment in the coming weeks, from the Company’s west coast manufacturing partner. Subsequent shipments will follow quickly thereafter. VICAR Holdings has recently formed with a central health and wellness mission, focused on the on-line sale of only the highest quality and performance products, featured in a premium “PrescriptionGrade” product line. The company’s website and online store are currently under construction, with the initial PrescriptionGrade products slated for Beta testing in March 2024, and fully launching into sales in Q2 2024. VICAR has proudly announced PBIO‘s Nano-CBD Topical Spray will be the first product available through their on-line store. The product will be sold as PrescriptionGrade Nano-CBD.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PBIO:
- Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order
- Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January
- Pressure BioSciences announces filling order with partner for Uncle Bud’s
- Pressure BioSciences evaluating AI, ML prospective partnerships
- Pressure BioSciences, VST launch Nano CBD Topical Spray
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue